Mettler-Toledo International, I vs Pfizer, Inc. — Stock Comparison
Mettler-Toledo International, I (MTD) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Mettler-Toledo International, I narrowly edges Pfizer, Inc. on Q·Score (6.1 vs 5.9 out of 10), led by Quality (7.3 vs 5) and Growth (7 vs 5.9). Pfizer, Inc. scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for MTD (+9.2%) than for PFE (+4.8%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Strong profitability with 22% net profit margins.
⚠ high leverage at 166.7× debt-to-equity.
Consistently beats earnings estimates (4/4 quarters).
⚠ weak profitability metrics drag quality score.
Analyst Consensus
Fundamentals
Frequently Asked Questions
MTD vs PFE: which stock scores better overall?
Based on Q·Score, Mettler-Toledo International, I (MTD) scores 6.1/10 versus Pfizer, Inc. (PFE) at 5.9/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MTD or PFE?
Mettler-Toledo International, I (MTD) scores higher on Growth (7/10 vs 5.9/10). Mettler-Toledo International, I reports revenue growth (4.5% YoY) while Pfizer, Inc. reports (2.6% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MTD or PFE more attractively valued?
Mettler-Toledo International, I (MTD) scores higher on Valuation (6.5/10 vs 6.2/10). MTD trades at 25.7× P/E versus PFE at 9.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MTD vs PFE?
There are 14 analysts covering MTD with a consensus price target of $1452.50, and 26 analysts covering PFE with a consensus target of $28.88. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MTD or PFE?
Mettler-Toledo International, I (MTD) scores higher on Quality (7.3/10 vs 5/10). Net profit margin: MTD at 21.9%, PFE at 6.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MTD or PFE?
Pfizer, Inc. (PFE) scores higher on Financial Health (7/10 vs 4.5/10). Market beta: MTD at 1.22, PFE at 0.30. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MTD and PFE?
Mettler-Toledo International, I (MTD) has a market capitalisation of $26.7B, while Pfizer, Inc. (PFE) has a market cap of $157.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MTD or PFE pay dividends?
MTD does not currently pay a dividend, while PFE pays a dividend yield of 6.20%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →